Internal Medicine, Rheumatology · Lakewood, WA
NPI
1760481048
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
11311 Bridgeport Way SW, Ste 214
Lakewood, WA, 98499
Phone (253) 985-6490
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,025 services
Medicare patients, 2024
517
Average age 72
Drug cost, 2024
$7.7M
5,353 prescriptions
Company payments, 2025
$898
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zhiqian Wang was code 99214 (office e&m - established), 723 times for 420 patients. In total Zhiqian Wang billed 1,025 services in 12 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-01-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 723 | 420 | $90.58 | $65K |
| 99211 Office E&M - Established | Office | 101 | 66 | $17.13 | $1,730 |
| 99215 Office E&M - Established | Office | 100 | 90 | $123.97 | $12K |
| 99204 Office E&M - New | Office | 43 | 43 | $120.40 | $5,177 |
| 99213 Office E&M - Established | Office | 20 | 19 | $57.65 | $1,153 |
By year: 2022 $96K for 1,348 services; 2023 $85K for 1,148 services; 2024 $88K for 1,025 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zhiqian Wang prescribed most often to Medicare patients was Prednisone, with 774 prescriptions and refills. In total Zhiqian Wang wrote 5,353 Medicare prescriptions that cost $7.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 774 | 1,093 | 277 | $5,041 |
| Hydroxychloroquine Sulfate Generic | 664 | 1,677 | 222 | $34K |
| Methotrexate Methotrexate Sodium | 590 | 1,172 | 165 | $14K |
| Mycophenolate Mofetil Generic | 295 | 461 | 67 | $25K |
| Tramadol Hcl Generic | 175 | 175 | 32 | $1,678 |
| Humira(Cf) Pen Adalimumab | 173 | 184 | 30 | $1.3M |
| Enbrel Sureclick Etanercept | 148 | 154 | 24 | $1.1M |
| Rinvoq Upadacitinib | 147 | 164 | 23 | $1.0M |
| Folic Acid Generic | 139 | 405 | 48 | $1,362 |
| Methylprednisolone Generic | 123 | 148 | 58 | $1,359 |
| Sulfasalazine Generic | 121 | 185 | 24 | $2,475 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 90 | 91 | 13 | $702K |
| Methotrexate Sodium Methotrexate Sodium/Pf | 87 | 109 | 17 | $1,027 |
| Diclofenac Sodium Generic | 83 | 104 | 32 | $3,573 |
| Gabapentin Generic | 77 | 118 | 16 | $1,527 |
Brand drugs: 1,303 claims; generic drugs: 4,011 claims; opioid claims: 273.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zhiqian Wang $898 ($898 in general payments such as food, travel and fees) from 4 companies. The largest payer was Amgen Inc. with $439.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.